Stock Price
41.39
Daily Change
0.21 0.51%
Monthly
-9.00%
Yearly
11.07%
Q1 Forecast
40.37

Qiagen NV reported $72.66M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
argenx SE USD 852.2M 369.5M Jun/2025
Avita Medical AUD 7.27M 976K Jun/2025
Dianthus Therapeutics USD 6.7M 1.3M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Moderna USD 317M 50M Dec/2025
Organon & Co USD 1.07B 7M Sep/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.48M 1.32M Sep/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025